Siemens Healthineers and Hill-Rom to Provide Comprehensive Diabetes Care for Primary Care Facilities

Malvern, PA |  May 07, 2018

• Siemens Healthineers and Hill-Rom’s relationship delivers comprehensive care tools to help manage patients’ diabetes and reduce associated risks.
• With this complete solution, primary healthcare providers can improve patient outcomes, potentially reduce overall costs, and satisfy diabetes-care quality measures in a single patient visit.


Siemens Healthineers and Hill-Rom (NYSE: HRC) signed a co-marketing agreement to provide a suite of point-of-care diagnostic instruments that, for the first time, enable primary healthcare providers in the U.S. to bridge gaps in diabetes care and satisfy value-based quality measures in a single office visit. The integrated offering incorporates the Siemens Healthineers DCA Vantage® Analyzer for HbA1c testing, the CLINITEK Status®+ Urine Chemistry Analyzer for kidney checks, and Hill-Rom’s Welch Allyn® RetinaVue™ Network and imaging technology for teleretinal exams.


Currently, more than 90 percent of U.S. payers use value-based quality measures such as the Healthcare Effectiveness Data and Information Set and the Merit-based Incentive Payment System to assess provider performance and evaluate whether healthcare providers are taking steps to improve patient outcomes.1 Providing comprehensive care for diabetes is an essential performance criterion within these quality measures.


Diabetes and comorbidities such as diabetic retinopathy and diabetic nephropathy cost the U.S. healthcare system billions of dollars annually.2 Healthcare systems endeavor to adopt holistic, streamlined and efficient solutions that will reduce this cost burden. The patient-centered solution from Siemens Healthineers and Hill-Rom offers physicians more control over patient care by accomplishing proactive testing and treatment during a single visit. This improved workflow may reduce costs and eliminate inconvenient follow-up visits, leading to higher patient satisfaction and compliance with care regimens. Comprehensive point-of-care testing for diabetes has improved patient outcomes.3 Studies show that by reducing a patient’s HbA1c level by one percent, the risk of kidney damage and eye damage also is reduced by 50 percent and 76 percent, respectively.4 More than 80 percent of Americans living with diabetes will eventually develop diabetic retinopathy5—the leading cause of blindness among working age adults.6 With early detection, 95 percent of vision loss can be prevented,7 yet less than half of patients with diabetes get an annual eye exam.8


“A patient’s quality of life declines significantly when chronic diseases remain untreated, which is why testing for comorbidities is so important,” said Mike Sampson, senior vice president of Point of Care Diagnostics, North America, Siemens Healthineers. “Our new commercial relationship with Hill-Rom will provide holistic, easy-to-implement solutions that aid in combating diabetes and related comorbidities while satisfying value-based quality care measures. With operator-friendly analyzers that generate lab-quality results in minutes and capabilities to integrate test results with electronic health records, physicians can make immediate treatment decisions and improve long-term outcomes.”


Siemens Healthineers contributes to the joint offering with point-of-care solutions that aid in combating chronic diseases before they become critical. The DCA Vantage® Analyzer monitors a patient’s glycemic control in minutes with CLIA-waived HbA1c testing. With the CLINITEK Status®+ Urine Chemistry Analyzer, healthcare providers can perform a kidney check in 60 seconds with CLIA-waived albumin-to-creatinine ratio testing.


With Hill-Rom’s Welch Allyn RetinaVue Network™ offering, physicians perform in-office diabetic retinal exams, capturing images in seconds with nonmydriatic cameras. The images are transmitted through HIPAA-compliant software for interpretation by a nationwide team of board-certified ophthalmologists. Evaluating retinal health in primary care settings can be highly effective— with some achieving over 90 percent diabetic retinal eye exam compliance in a single year,9 resulting in timely, vision-saving treatment.


“Hill-Rom and Siemens Healthineers share a common vision to put patients on a better path to healthcare by providing solutions that allow our customers to transform care delivery with greater efficiency and effectiveness,” said Alton Shader, president of Hill-Rom’s Front Line Care business, which includes Welch Allyn. “We have a tremendous opportunity in front of us and we are excited to activate this vision.”


Hill-Rom’s Welch Allyn RetinaVue™ Network is the largest tele-ophthalmology services network in the U.S., serving more than 2,000 primary care clinics and partnering with leading commercial health plans and insurers nationwide. RetinaVue, P.C. is the first tele-ophthalmology services network to receive The Joint Commission’s Gold Seal of Approval® for Ambulatory Health Care Accreditation. Siemens Healthineers is the largest manufacturer of point-of-care solutions for diabetes and urinalysis testing.


Visit this link for further information on this collaboration.


3 Medical and Surgical Clinic of Irving Rajiv Dattatreya, MD. Customer testimonial. Signed release on file.
4 DCCT; UKPD; ADA Standards of Medical Care in Diabetes, 2005. Bode BW (ed.). Medical management of type 1 diabetes.
5 Preferred Practice Pattern® Guidelines, page 6. American Academy of Ophthalmology; 2014.
6 CDC Vision Health Initiative (VHI), Common Eye Disorders.
7 National Eye Institute, Facts About Diabetic Eye Disease.
8 Monitoring Visual Status: Why Patients Do or Do Not Comply with Practice Guidelines
9 Comparing the Effectiveness of Telemedicine and Traditional Surveillance in Providing Diabetic Retinopathy Screening Examinations: A Randomized Controlled Trial




Contact for journalists
Kimberly Nissen, Siemens Healthineers
Phone: +1 610-448-6355; Email:

Howard Karesh, Hill-Rom
Phone: +1-312-819-7268; Email:


About Siemens Healthineers
Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. In fiscal 2017, which ended on September 30, 2017, Siemens Healthineers generated revenue of €13.8 billion and profit of €2.5 billion and has about 48,000 employees worldwide. Further information is available at


About Hill-Rom
Hill-Rom is a leading global medical technology company whose products, services and more than 10,000 employees worldwide help people get better care inside and outside the hospital. Our innovations in five core areas – Advancing Mobility, Wound Care and Prevention, Patient Monitoring and Diagnostics, Surgical Safety and Efficiency, and Respiratory Health – improve clinical and economic outcomes and ensure caregivers in more than 100 countries have the products they need to protect their patients, speed up recoveries and manage conditions. Every day, around the world, we enhance outcomes for patients and their caregivers. Learn more at



Share this page: